NASDAQ$CORZ

Core Scientific · Q2 2023 earnings

Q2 2023 earnings ·

Headline financials

Total Revenue

$127M

Previous: $164M-22.6%
EPS

-$0.02

Previous: -$2.49+99.2%
Capital Expenditures

-$1.77M

Previous: -$239M+99.3%
Free Cash Flow

-$11M

Previous: -$1.05B+98.9%
Net Income

-$9.26M

Previous: -$810M+98.9%
Operating Income

$9.38M

Previous: -$1.05B+100.9%
Gross Profit

$37M

Previous: $12.7M+190.6%
Cash & Equivalents

$57.6M

Previous: $129M-55.2%
Total Assets

$751M

Previous: $1.85B-59.3%

Revenue & EPS history

Core Scientific · Revenue · Quarterly

$127M

Q2 2023-22.6%vs Q2 2022
Beat estimate in 1 of 5 quarters(20%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports

Historical avg

+3.9%

Avg return

Earnings day

+6.3%

Avg return

5 days after

+20.6%

Avg return

30 days after

75%

6 / 8 earnings

Positive

+11.0%

Q1 2026

Best reaction

-7.2%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+11.0%+3.4%+16.5%
Q4 2025-7.2%-9.9%-1.6%
Q3 2025+0.0%+7.2%-18.6%
Q1 2025+6.2%+15.1%+37.0%
Q4 2024+6.9%-4.3%-25.3%
Q3 2024+10.1%+34.2%+30.5%
Q2 2024+1.1%-2.5%-4.0%
Q1 2024+3.0%+7.5%+130.2%
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Q1 2022

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro